The company said its Board of Directors increased the number of authorized directors from 8 to 9 on July 24, 2024. Barbara Burger, Ph.D. was appointed as a Class II director effective August 1, 2024.

1. 01

   The company said its Board of Directors increased the number of authorized directors from 8 to 9 on July 24, 2024. Barbara Burger, Ph.D. was appointed as a Class II director effective August 1, 2024.

2. 02

   The company said Dr. Burger will serve until the 2026 annual meeting of stockholders and has also been appointed to the Nominating, Governance, and Public Policy Committee.

3. 03

   The company said Dr. Burger served as Vice President, Innovation at Chevron and President of Chevron Technology Ventures from June 2013 to April 2022, and has been a member of the Heliogen, Inc. board since September 2022.

4. 04

   The company said its Board amended non-employee director compensation on May 2024, replacing the pro-rated RSU grant for directors with an initial equity award with a fair value of approximately $350,000 that vests in equal annual installments over 3 years, and that Dr. Burger elected to receive RSUs.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.